50.08 USD
↗ 0.96 (1.95%)AT CLOSE (11:59 AM EDT)
Enliven Therapeutics, Inc. Common Stock
ELVNNASDAQ • USD
50.07
↘ 0.01 (0.02%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
50.07
↘ 0.01 (0.02%)
Market: CLOSED
ELVN is currently priced at $50.08. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, ELVN trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 26, 2026.
Open?$49.00
High?$50.45
Low?$48.47
Prev. Close?$49.12
Volume?6.7M
Avg. Volume?1.8M
VWAP?$49.45
Rel. Volume?3.72x
Bid / Ask
Bid?$41.28 × 100
Ask?$57.86 × 100
Spread?$16.58
Midpoint?$49.57
Valuation & Ratios
Market Cap?3.6B
Shares Out?60.9M
Float?45.4M
Float %?76.5%
P/E Ratio?N/A
P/B Ratio?7.89
EPS?-$1.38
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Employees
61
Market Cap
3.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-02-24
Address
6200 LOOKOUT ROAD
BOULDER, CO 80301
Phone: 720-647-8519
BOULDER, CO 80301
Phone: 720-647-8519
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?65
Short Sent.?66
Piotroski F-Score?0/9Weak
Altman Z-Score?186.10Safe
Confidence?49%Low
Short InterestHigh
Short % of Float?11.96%High
Short Interest?5.4M
Days to Cover?2.6
Free Float45.4M
Avg Daily Volume2.1M
Settlement Date2026-06-15
Financial Health
Current Ratio?40.32Strong
Quick Ratio?40.32Strong
Cash Ratio?11.51Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?7.89FAIR▾
Peers100
S&P24
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-29.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-21.8%WEAK▾
S&P7
ROA?-21.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-65603000
Enterprise Value?$3.4B
Fundamentals ratios updated end of day